Actionable news
All posts from Actionable news
Actionable news in JNJ: JOHNSON & JOHNSON,

Actelion Shares Top Swiss Market Despite Opsumit Drug Test Disappointment

Actelion Pharmaceuticals' (ALIOY) shares led Zurich stocks higher Monday despite the company's admission that its potential blockbuster Opsumit drug failed to meet a key target in late-stage trials.

Opsumit, a follow-up to the Swiss biotech's Tracleer treatment for patients with pulmonary arterial hypertension, missed a Phase 3 trial goal, measured by a "six minute walk test", the company said Monday.

"Although the results point towards a benefit of treatment with macitentan, we...